Comparison of two site-specifically 18F. Labeled affibodies for PET imaging of EGFR positive tumors

Molecular Pharmaceutics

Volumn 11, Issue 11, 2014, Pages 3947-3956

  Su, Xinhui ^a,b   Cheng, Kai ^b   Jeon, Jongho ^b,c   Shen, Bin ^b   Venturin, Gianina Teribele ^b,d   Hu, Xiang ^b   Rao, Jianghong ^b   Chin, Frederick T ^b   Wu, Hua ^e   Cheng, Zhen ^b  

^a XIAMEN UNIVERSITY   (China)

^b STANFORD UNIVERSITY   (United States)

^c Korea Atomic Energy Research Institute   (South Korea)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

^{18< sup>F; Affibody; CBT; EGFR; NOTA; PET}

Indexed keywords

2 CYANOBENZOTHIAZOL Z EPIDERMAL GROWTH FACTOR RECEPTOR 1907 F 18; ALUMINUM 1,4,7 TRIAZACYCLONONANE TRIACETIC ACID Z EPIDERMAL GROWTH FACTOR RECEPTOR 1907 F 18; EPIDERMAL GROWTH FACTOR RECEPTOR; TRACER; UNCLASSIFIED DRUG; 2-CYANOBENZOTHIAZOLE; BENZOTHIAZOLE DERIVATIVE; COPPER; FLUORINE; FLUORODEOXYGLUCOSE F 18; NITRILE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE TUMOR; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG STABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; MUSCLE TUMOR; NEOPLASM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; TUMOR XENOGRAFT; AMINO ACID SEQUENCE; ANIMAL; CANCER TRANSPLANTATION; CHEMISTRY; COMPARATIVE STUDY; HUMAN; KIDNEY; MOLECULAR GENETICS; NUDE MOUSE; PROTEIN TERTIARY STRUCTURE; SCINTISCANNING; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; BENZOTHIAZOLES; CELL LINE, TUMOR; COPPER RADIOISOTOPES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NITRILES; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84925492710     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5003043     Document Type: Article

References (25)

1. Mendelsohn, J.; Baselga, J. Epidermal growth factor receptor targeting in cancer. Semin. Oncol. 2006, 33 (4), 369-385.
2. Chen, S. J.; Luan, J.; Zhang, H. S.; Ruan, C. P.; Xu, X. Y.; Li, Q. Q.; Wang, N. H. EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells. Mol. Biol. Rep. 2012, 39 (5), 5465-5471.
3. Hoffmann, K.; Xiao, Z.; Franz, C.; Mohr, E.; Serba, S.; Büchler, M. W.; Schemmer, P. Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro. Cancer Cell Int. 2011, 11, 40.
4. Liang, K.; Ang, K. K.; Milas, L.; Hunter, N.; Fan, Z. The epidermal growth factor receptor mediates radioresistance. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57 (1), 246-254.
5. Pantaleo, M. A.; Nannini, M.; Maleddu, A.; Fanti, S.; Nanni, C.; Boschi, S.; Lodi, F.; Nicoletti, G.; Landuzzi, L.; Lollini, P. L.; Biasco, G. Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer. Ann. Oncol. 2009, 20 (2), 213-226.
6. Friedman, M.; Nordberg, E.; Hoïdén-Guthenberg, I.; Brismar, H.; Adams, G. P.; Nilsson, F. Y.; Carlsson, J.; Stahl, S. Phage display selection of affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor. Protein Eng. Des. Sel. 2007, 20 (4), 189-199.
7. Cheng, Z.; De Jesus, O. P.; Kramer, D. J.; De, A.; Webster, J. M.; Gheysens, O.; Levi, J.; Namavari, M.; Wang, S.; Park, J. M.; Zhang, R.; Liu, H.; Lee, B.; Syud, F. A.; Gambhir, S. S. 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. Mol. Imaging Biol. 2010, 12 (3), 316-324.
8. Cheng, Z.; De Jesus, O. P.; Namavari, M.; De, A.; Levi, J.; Webster, J. M.; Zhang, R.; Lee, B.; Syud, F. A.; Gambhir, S. S. Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J. Nucl. Med. 2008, 49 (5), 804-813.
9. Ren, G.; Zhang, R.; Liu, Z.; Webster, J. M.; Miao, Z.; Gambhir, S. S.; Syud, F. A.; Cheng, Z. A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression. J. Nucl. Med. 2009, 50 (9), 1492-1499.
10. Webster, J. M.; Zhang, R.; Gambhir, S. S.; Cheng, Z.; Syud, F. A. Engineered two-helix small proteins for molecular recognition. ChemBioChem 2009, 10 (8), 1293-1296.
11. Baum, R. P.; Prasad, V.; Müller, D.; Schuchardt, C.; Orlova, A.; Wennborg, A.; Tolmachev, V.; Feldwisch, J. Molecular imaging of HER2-expressing malignant tumors in breast cancer patient using synthetic 111In- or 68Ga-labeled affibody molecules. J. Nucl. Med. Med. 2010, 51 (6), 892-897.
12. Miao, Z.; Ren, G.; Liu, H.; Qi, S.; Wu, S.; Cheng, Z. PET of EGFR expression with an 18F-labeled affibody molecule. J. Nucl. Med. 2012, 53 (7), 1110-1118.
13. Miao, Z.; Ren, G.; Liu, H.; Jiang, L.; Cheng, Z. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. Bioconjugate Chem. 2010, 21 (5), 947-954.
14. McBride, W. J.; Sharkey, R. M.; Karacay, H.;D'Souza, C. A.; Rossi, E. A.; Laverman, P.; Chang, C. H.; Boerman, O. C.; Goldenberq, D. M. A novel method of 18F radiolabeling for PET. J. Nucl. Med. 2009, 50 (6), 991-998.
15. Laverman, P.; McBride, W. J.; Sharkey, R. M.; Eek, A.; Joosten, L.; Oyen, W. J.; Goldenberq, D. M.; Boerman, Q. C. A novel facile method of labeling octreotide with (18)F-fluorine. J. Nucl. Med. 2010, 51 (3), 454-461.
16. Jeon, J.; Shen, B.; Xiong, L.; Miao, Z.; Lee, K. H.; Rao, J.; Chin, F. T. Efficient method for site-specific 18F-labeling of biomolecules using the rapid condensation reaction between 2-cyanobenzothiazole and cysteine. Bioconjugate Chem. 2012, 23 (9), 1902-1908.
17. Heskamp, S.; Laverman, P.; Rosik, D.; Boschetti, F.; van der Graaf, W. T.; Oyen, W. J.; van Laarhoven, H. W.; Tolmachev, V.; Boerman, O. C. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. J. Nucl. Med. 2012, 53 (1), 146-153.
18. Liu, S.; Liu, H.; Jiang, H.; Xu, Y.; Zhang, H.; Cheng, Z. One-step radiosynthesis of 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging. Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (9), 1732-1741.
19. Wan, W.; Guo, N.; Pan, D.; Yu, C.; Weng, Y.; Luo, S.; Ding, H.; Xu, Y.; Wang, L.; Lang, L.; Xie, Q.; Yang, M.; Chen, X. First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J. Nucl. Med. 2013, 54 (5), 691-698.
20. Kareem, H.; Sandström, K.; Elia, R.; Gedda, L.; Anniko, M.; Lundqvist, H.; Nestor, M. Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF. Tumour Biol. 2010, 31 (2), 79-87.
21. Malmberg, J.; Perols, A.; Varasteh, Z.; Altai, M.; Braun, A.; Sandström, M.; Garske, U.; Tolmachev, V.; Orlova, A.; Karlström, A. E. Comparative evaluation of synthetic anti-HER2 Affibody molecules sitespecifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts. Eur. J. Nucl. Med. Mol. Imaging 2012, 39 (3), 481-492.
22. van Eerd, J. E.; Vegt, E.; Wetzels, J. F.; Russel, F. G.; Masereeuw, R.; Corstens, F. H.; Oyen, W. J.; Boerman, O. C. Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats. J. Nucl. Med. 2006, 47 (3), 528-533.
23. Vegt, E.; van Eerd, J. E.; Eek, A.; Oyen, W. J.; Wetzels, J. F.; de Jong, M.; Russel, F. G.; Masereeuw, R.; Gotthardt, M.; Boerman, O. C. Reducing renal uptake of radiolabeled peptides using albumin fragments. J. Nucl. Med. 2008, 49 (9), 1506-15 11.
24. Rolleman, E. J.; Valkema, R.; de Jong, M.; Kooij, P. P.; Krenning, E. P. Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine. Eur. J. Nucl. Med. Mol. Imaging 2003, 30 (1), 9-15.
25. Fani, M.; Maecke, H. R.; Okarvi, S. M. Radiolabeled peptides: Valuable tools for the detection and treatment of cancer. Theranostics 2012, 2 (5), 481-501.